`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`PAR PHARMACEUTICAL, INC.,
`Petitioner
`
`v.
`
`SUMITOMO DAINIPPON PHARMA CO., LTD.,
`Patent Owner
`
`Case IPR2017-01292
`U.S. Patent No. 9,555,027
`
`DECLARATION OF JOSEPH M. O’MALLEY, JR.
`
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:20) (cid:82)(cid:73) (cid:22)
`
`SUMITOMO EX. 2001
`PAR v. SUMITOMO
`IPR2017-01292
`
`
`
`Case IPR2017-01292
`U.S. Patent 9,555,027
`
`I, Joseph M. O’Malley, Jr., declare:
`
`1.
`
`2.
`
`I am a member in good standing of the Bar of the State of New York.
`
`I am an attorney at Paul Hastings LLP. I am an experienced litigating
`
`attorney with more than twenty-four years of experience practicing patent law. In
`
`that time, I have served as lead counsel in numerous patent infringement suits
`
`before the district courts and the Court of Appeals for the Federal Circuit.
`
`3.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`4.
`
`I have never had an application for admission to practice before any
`
`court or administrative body denied.
`
`5.
`
`I have never had sanctions or contempt citations imposed by any court
`
`or administrative body.
`
`6.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42 of title 37 of
`
`the Code of Federal Regulations.
`
`7.
`
`I agree to be subject to the USPTO Rules of Professional Conduct set
`
`forth in 37 C.F.R. §§ 11.101, et seq. and disciplinary jurisdiction under 37 C.F.R. §
`
`11.19(a).
`
`8.
`
`I have not applied to appear pro hac vice in any other proceeding
`
`before the U.S. Patent and Trademark Office in the last three years.
`
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:21) (cid:82)(cid:73) (cid:22)
`
`2
`
`
`
`Case IPR2017-01292
`U.S. Patent 9,555,027
`
`9.
`
`I am familiar with the subject matter at issue in this proceeding. I
`
`have reviewed U.S. Patent No. 9,555,027 (“the ’027 patent”), the patent-at-issue,
`
`and other papers associated with this matter. I have handled patent litigation
`
`matters involving lurasidone, an ingredient in the oral preparations claimed in the
`
`’027 patent. See, e.g., Paper 1 at 1.
`
`10.
`
`I hereby declare under penalty of perjury under the laws of the United
`
`States of America that the foregoing is true and correct, and that all statements
`
`made of my own knowledge are true and that all statements made on information
`
`and belief are believed to be true. I understand that willful false statements are
`
`punishable by fine or imprisonment or both. See 18 U.S.C. § 1001.
`
`
`
`Date: May 10, 2017
`
`
`
`
`Respectfully submitted,
`
`/Joseph M. O’Malley, Jr./
`Joseph M. O’Malley, Jr.
`PAUL HASTINGS LLP
`200 Park Avenue
`New York, New York 10166
`
`(cid:51)(cid:68)(cid:74)(cid:72) (cid:22) (cid:82)(cid:73) (cid:22)
`
`3
`
`